Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No visible changes to study content.
    Difference
    0.1%
    Check dated 2026-03-12T02:22:37.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag was added and the earlier Revision: v3.4.1 funding-status notice was removed, which are maintenance updates that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:47:05.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and NIH operations status; updated the site to version 3.4.1 and removed the 3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:14:37.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A glossary toggle was added to the page. Minor metadata updates were made, including the label 'Last Update Submitted that Met QC Criteria', capitalization of 'No FEAR Act data', and the revision note 'v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T05:10:04.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown, replacing Revision: v3.3.3. This is a minor UI/version update and does not alter study details or user actions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:11:50.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Added a Locations section listing state sites (Arizona, California, Colorado, Massachusetts, New Jersey, Pennsylvania, Washington) and updated the revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the previous revision tag (v3.3.2).
    Difference
    0.8%
    Check dated 2025-12-23T20:37:49.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.